Options traders and short sellers are converging on ZTS from multiple angles. The stock has dropped 4.3% over the past month. Earnings land on August 5.
The loudest signal here is the relentless analyst price-target compression. HSBC slashed its target from $140 to $95 on July 6. Barclays cut from $136 to $85 on July 1. TD Cowen dropped from $150 to $104 the day before that. The consensus mean now sits at $113.82 — still 51% above Tuesday's close of $75.35. That gap is narrowing fast.
The May 7 earnings print was the catalyst. ZTS fell 25.5% that day and lost 32.1% over the following five days. Argus Research downgraded to Hold shortly after. The pattern since has been one-way: firm after firm maintaining their ratings but hacking at targets.
The put-call ratio hit 0.628 on July 21 — the highest in two weeks. The 20-day mean is 0.49. That puts the PCR z-score at 2.14, a statistically elevated reading. Options traders are buying protection at a pace well above recent norms, with August 5 earnings now just two weeks away.
Short interest stands at 3.9% of free float — modest in absolute terms but moving. It has risen 24.4% over the past month and 6.0% over the past week. The ORTEX short score ticked up to 37.4 on July 20, from 35.0 a week earlier.
Cost to borrow jumped 74% over the past week to 0.51%. That is still a low absolute rate. Availability remains extremely loose at 2,358% — roughly 353 million shares available against roughly 17 million currently lent. The borrow market is not a constraint here.
One counterpoint: three directors bought shares in May at prices between $75 and $78. Frank Damelio picked up 6,650 shares ($501K). The Independent Chairman bought 3,000 shares ($233K). These are small positions relative to the company, but the timing — right at current price levels — is notable ahead of an earnings event with outsized historical moves.
What to watch: The August 5 print. Last quarter's 25% single-day drop reset the bar sharply. Whether that was a clearing event or the start of a longer re-rating is the question the options market is currently pricing with unusual intensity.
See the live data behind this article on ORTEX.
Open ZTS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
ZTS is drifting near the floor of its post-earnings collapse, and the question this week is whether the analyst community has finished cutting or has more room to go. The stock closed at $76.39 on June 2, down nearly…
ZTS enters the final stretch of May with a clear internal vs. external disconnect. Three directors stepped in to buy shares at post-earnings lows in mid-May — yet the Street spent the same weeks racing to slash price…
